Alfred Yellson

PHD Doctor of Philosophy,  CharitĂ© - Universitätsmedizin Berlin 

Location: Africa

Consulting Services

Pharma-CRO-Device Legal Support Data Science-Bioinformatics Sales and Marketing

Areas Of Interest

Toxoplasmoses, Ocular Swings, Baby Respiratory Tract Absorption E2F Transcription Factor 5 Protein Food Service, Hospital Cytosolic Chaperonin Transition of Care First Generation H1 Antagonists Palliative Treatment Control, Infection Dentine Hypersensitivity Vestibular Neuritis Crepis capillari Bed Rest Sanaa Orphan Nuclear Receptor TR2 Karyotype, Abnormal Infectious Bursal Agent Clearance Rate, Metabolic Prolyl-Leucyl-Glycinamide Dialysis Solutions Transcription, Late Gene Agonist, gamma-Aminobutyric Acid IL-4 Receptors Biological Phenomenon beta-Aminoethylisothiuronium Monohydrobromide Health Insurance, National Oxidoreductases Acting on CH-NH Group Donors Protein Antibodies, Anti-Citrullinated Filtration Rates, Glomerular Model, Logit

Professional Narrative

Dr. Alfred Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Senior Director, Mayo Clinic 1999
Executive Director, Mayo Clinic 2002

Education

Doctor of medicine, Baylor College 2013
Director Medicine, Baylor College 2000

Referees


Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :